Early Identification, Clinical Intervention Vital for MDD
A recent study published in the Journal of the American Medical Association indicated that among those with major depressive disorder (MDD), the elevated disease burden of treatment-resistant depression (TRD) on the patient and healthcare system may be diminished by early recognition and intervention. Find out more on the effects of long duration from MDD diagnosis until TRD.
|
Clinical Guideline Updated for MDD Acute Phase
The American College of Physicians recently published its updated guideline regarding clinical recommendations for nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder (MDD). The guideline emphasizes the importance of tailoring therapy to patient needs and the significance of shared decision-making between clinician and patient to improve adherence and clinical outcomes. Read more.
|